Equity Issuances

Vivos Therapeutics, Inc. issued 1,353,625 shares (the "PIPE Shares") of Common Stock of common stock to V-Co Investors 3 LLC for purchase price of $1.34 for each PIPE Share and Pre-Funded Warrant Share and associated Common Stock Purchase Warrants.

““ Warrants ”, and with the shares of Common Stock underlying the Common Stock Purchase Warrants being referred to as the “ Warrant Shares ”). V-Co 3 paid a purchase price of $1.34 for each PIPE Share and Pre-Funded Warrant Share and associated Common Stock Purchase Warrants, with such price being established for purposes of compliance with the listing rules”

Interactive Strength, Inc. issued 1,088,255 shares of preferred stock to Vertical Investors, LLC for payment of the $2,176,509 Net Trade Value.

“On March 31, 2026, the Company and the Lender entered into a Settlement Agreement (the “Settlement Agreement”), pursuant to which the Company issued 1,088,255 shares (the “Series C Preferred Shares”) of the Company’s Series C Preferred Stock, par value $0.0001 per share (“Series C Preferred Stock”), to the Lender as payment of the $2,176,509 Net Trade Value.”

Stone Point Credit Corp issued 1,267,767.846 shares of the Company's common stock on March 31, 2026; 495.141 shares of the Company's common stock on April 1, 2026 of common stock to investors under subscription agreements for aggregate offering price of $24,990,239.78 for the March 31 issuance and $9,760.22 for the April 1 issuance.

“Pursuant to a capital drawdown notice to its investors, Stone Point Credit Corporation (the "Company") issued and sold: (A) 1,267,767.846 shares of the Company’s common stock, par value $0.001 per share (the "Common Stock"), on March 31, 2026 for an aggregate offering price of $24,990,239.78; and (B) 495.141 shares of the Company’s Common Stock on April 1, 2026 for an aggregate offering price of $9,760.22.”

Goldman Sachs Private Credit Corp. issued 12,138 Class D Shares of common stock to accredited investors and Non-U.S. Persons for $300,000.

“As of March 1, 2026, Goldman Sachs Private Credit Corp. (the “Company”) sold unregistered Class I shares, Class S shares and Class D shares, as shown in the table below (collectively, the “Shares”) (with the final number of Shares being determined on April 2, 2026). The offer and sale of the Shares was exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) thereof, Regulation D thereunder and/or Regulation S thereunder. The following table details the Shares sold: Share Class Amount of Shares Consideration (in 000s) Class I Shares 6,553,873 $ 161,982 Class S Shares 80,881 $ 1,999 Class D Shares 12,138 $ 300 The sale of Shares was made pursuant to subscription agreements entered into by the Company and the purchasers thereof. The Company relied, in part, upon representations from the purchasers in the subscription agreements that each purchaser was an accredited investor (as defined in Regulation D under th”

Goldman Sachs Private Credit Corp. issued 80,881 Class S Shares of common stock to accredited investors and Non-U.S. Persons for $1,999,000.

“As of March 1, 2026, Goldman Sachs Private Credit Corp. (the “Company”) sold unregistered Class I shares, Class S shares and Class D shares, as shown in the table below (collectively, the “Shares”) (with the final number of Shares being determined on April 2, 2026). The offer and sale of the Shares was exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) thereof, Regulation D thereunder and/or Regulation S thereunder. The following table details the Shares sold: Share Class Amount of Shares Consideration (in 000s) Class I Shares 6,553,873 $ 161,982 Class S Shares 80,881 $ 1,999 Class D Shares 12,138 $ 300 The sale of Shares was made pursuant to subscription agreements entered into by the Company and the purchasers thereof. The Company relied, in part, upon representations from the purchasers in the subscription agreements that each purchaser was an accredited investor (as defined in Regulation D under th”

Goldman Sachs Private Credit Corp. issued 6,553,873 Class I Shares of common stock to accredited investors and Non-U.S. Persons for $161,982,000.

“As of March 1, 2026, Goldman Sachs Private Credit Corp. (the “Company”) sold unregistered Class I shares, Class S shares and Class D shares, as shown in the table below (collectively, the “Shares”) (with the final number of Shares being determined on April 2, 2026). The offer and sale of the Shares was exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) thereof, Regulation D thereunder and/or Regulation S thereunder. The following table details the Shares sold: Share Class Amount of Shares Consideration (in 000s) Class I Shares 6,553,873 $ 161,982 Class S Shares 80,881 $ 1,999 Class D Shares 12,138 $ 300 The sale of Shares was made pursuant to subscription agreements entered into by the Company and the purchasers thereof. The Company relied, in part, upon representations from the purchasers in the subscription agreements that each purchaser was an accredited investor (as defined in Regulation D under th”

Blue Owl Real Estate Net Lease Trust issued 17,753,975 of common stock to unknown for gross proceeds of approximately $188.7 million.

“On April 1, 2026, Blue Owl Real Estate Net Lease Trust (the “ Company ,” “ ORENT ” “ we ” or “ us ”) sold an aggregate of 17,753,975 of its common shares for gross proceeds of approximately $188.7 million, based on net asset value per share as of February 28, 2026.”

IPC Alternative Real Estate Income Trust, Inc. issued 7,452 shares of common stock to accredited investors for $23.4833 per share, aggregate $175,000.

“On April 1, 2026, IPC Alternative Real Estate Income Trust, Inc. (the “Company”) issued 7,452 shares of Class X-1 common stock at a price per share of $23.4833 to accredited investors in a private placement for an aggregate purchase price of $175,000.”

CAMPBELL FUND TRUST issued unit to existing and/or new unitholders of Registrant for $980,000.00, $805,294.11 and $275,000.00 in cash for Series A, Series D and Series W, respectively.

“Act of 1933, as amended (the “Securities Act”). The aggregate estimate consideration for Units of Beneficial Interest, excluding escrow interest, sold on March 31, 2026 was $980,000.00, $805,294.11 and $275,000.00 in cash for Series A, Series D and Series W, respectively. The Units of Beneficial Interest were issued by Registrant in reliance upon an exemption”

AYTU BIOPHARMA, INC issued warrant to institutional investors for exchange of existing warrants for amended warrants.

“On March 31, 2026, the Company and the Investors, as applicable, entered into (i) an Amended and Restated June 2023 Prefunded Warrant (“Amended 2023 Prefunded Warrant”), (ii) an Amended and Restated June 2023 Tranche A Warrant (“Amended 2023 Tranche A Warrant”) and (iii) an Amended and Restated June 2025 Prefunded Warrant (“Amended 2025 Prefunded Warrant”), pursuant to which the Company canceled the previously issued Warrants and issued to the Investors, as applicable, an Amended 2023 Prefunded Warrant, an Amended 2023 Tranche A Warrant and an Amended 2025 Prefunded Warrant, with revised Blockers.”

Hoth Therapeutics, Inc. issued warrants to purchase up to an aggregate of 2,857,144 shares of common stock of warrant.

“Additionally, in a concurrent private placement, the Company issued and sold unregistered warrants to purchase up to an aggregate of 2,857,144 shares of common stock at an exercise price of $0.85 per share.”

Hoth Therapeutics, Inc. issued 2,857,144 shares of its common stock (or common stock equivalents in lieu thereof) of common stock for $0.70 per share.

“Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering NEW YORK, April 2, 2026 – Hoth Therapeutics, Inc. (Nasdaq: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical needs, today announced the closing of its previously announced registered direct offering for the purchase and sale of an aggregate of 2,857,144 shares of its common stock (or common stock equivalents in lieu thereof) at an offering price of $0.70 per share of common stock (or per common stock equivalent in lieu thereof).”

VEEA INC. issued 43,236 shares of Preferred Stock of preferred stock to NLabs Inc. for $4,323,600 in unpaid rent and fees.

“On March 30, 2026, the Rent and Fees having an aggregate of $4,323,600 were converted into 43,236 shares of Preferred Stock.”

VEEA INC. issued 168,764 shares of Preferred Stock of preferred stock to NLabs Inc. for $16,876,400 in principal and accrued interest under promissory notes.

“On March 30, 2026, the Demand Notes having an aggregate of $16,876,400 in principal and accrued interest were converted into 168,764 shares of Preferred Stock.”

Alternus Clean Energy, Inc. issued 7,583 shares of Series D Convertible Preferred Stock and 684 shares of Series E Convertible Preferred Stock of preferred stock to two existing third party accredited debt holders for total repayment for, and the replacement and cancellation of, outstanding promissory notes in aggregate amount of $7.583 million and $684 thousand.

“on March 31, 2026 the Company settled with two existing third party accredited debt holders, pursuant to which the Company issued (i) 7,583 shares of Series D Convertible Preferred Stock as total repayment for, and the replacement and cancellation of, an outstanding promissory note in the aggregate amount of $7.583 million, and (ii) 684 shares of Series E Convertible Preferred Stock (the “Series E”) as total repayment for, and the replacement and cancellation of, two outstanding promissory notes in the aggregate amount of $684 thousand.”

Alternus Clean Energy, Inc. issued 2,150 shares of Series D Convertible Preferred Stock of preferred stock to a certain third party accredited investor for aggregate gross proceeds of $1,000,000.

“par value $0.0001 per share (the “Shares”) to the Purchaser. The transaction closed on March 27, 2026 (the “Closing Date”). The aggregate gross proceeds to the Company were $1,000,000, all of which were transferred on the Closing Date. The Company intends to use the net proceeds from the Offering for working capital and other general corporate purposes. Put”

Muzinich Corporate Lending Income Fund, Inc. issued common stock for $5,000,000 worth of shares.

“On April 1, 2026, Muzinich Corporate Lending Income Fund, Inc. (the "Company") sold approximately $5,000,000 worth of shares of the Company’s common stock, par value $0.001 per share (the "Common Stock").”

Trans American Aquaculture, Inc issued warrant to purchase up to 243,750,000 shares of Common Stock of warrant to GHS Investments LLC for exercise price of $0.000161 per share.

“the Company issued to GHS a warrant to purchase up to 243,750,000 shares of Common Stock at an exercise price of $0.000161 per share”

Trans American Aquaculture, Inc issued six shares of Series D Preferred Stock as commitment shares of preferred stock to GHS Investments LLC.

“GHS purchased 59 shares of Series D Preferred Stock and was issued an additional six shares of Series D Preferred Stock as commitment shares”

Trans American Aquaculture, Inc issued fifty-nine (59) shares of Series D Preferred Stock of preferred stock to GHS Investments LLC for purchase price of $1,000 per share, for an aggregate purchase price of $59,000.

“Investments LLC (“ GHS ”) pursuant to which the Company agreed to sell to GHS, at the initial closing, fifty-nine (59) shares of Series D Preferred Stock at a purchase price of $1,000 per share, for an aggregate purchase price of $59,000 (with $3,000 in legal fees reimbursable to GHS, which may be paid in cash or in shares of Series D Preferred Stock). Each”

Summit Midstream Corp issued 1,351,351 shares of common stock to affiliate of Tailwater Capital LLC for $42 million ($31.08 per share).

“Summit Midstream Corporation (NYSE: SMC) ("Summit", "SMC" or the "Company") announced today that it and its subsidiary, Summit Midstream Partners, LP (the "Partnership"), have entered into a securities purchase agreement with an affiliate of Tailwater Capital LLC ("Tailwater"), for a private placement of 1,351,351 shares of the Company's common stock, at a price of $31.08 per share.”

BlackRock Monticello Debt Real Estate Investment Trust issued 646,159.5315 common shares of common stock for $16,196,500.

“on April 1, 2026, the Company sold an aggregate of 646,159.5315 common shares (the "Shares") for aggregate consideration of $16,196,500, plus applicable upfront selling commissions and dealer manager fees”

ISQ Open Infrastructure Co LLC issued 180,438 Series I F-S TE Shares, 17,354 F-I TE Shares, 44,988 F-J TE Shares, 132,395 Series II F-S Shares, 124,460 F-I Shares, 335,538 F-J Shares, 40,735 E Share of securities to accredited investors and/or non-U.S. investors outside the United States for aggregate net consideration of $28,284,860.

“of March 1, 2026 held by third parties. * Share and dollar amounts rounded to the nearest whole number. The Company issued such shares for total aggregate net consideration of $28,284,860 (the “Proceeds”). The offer and sale of the shares above were exempt from the registration provisions of the Securities Act of 1933, as amended, by virtue of Section 4(a)(2),”

PIMCO Asset-Based Lending Co LLC issued securities to third party investors.

“On March 2, 2026, PIMCO Asset-Based Lending Company LLC (the “Company”) (including PIMCO Asset-Based Lending Company LLC - Series I (“Series I”) and PIMCO Asset-Based Lending Company LLC - Series II (“Series II” and, together with Series I, the “Series”)) issued and sold the following unregistered limited liability company interests of the Company (the “Shares”) for each of Series I and Series II (with the final number of Shares of each class (each, a “Class”) being determined on March 28, 2026) to third party investors for cash: Class Number of Shares Sold (1) Aggregate Consideration (1) Series I Anchor I Shares - $ - Anchor II Shares 6,655 67,962 Anchor II-B Shares - - E Shares 1,190 12,232 Standard A Shares 122 1,239 Standard B Shares - - Series II Anchor I Shares 958,857 $ 9,914,833 Anchor II Shares 1,212,663 12,507,462 Anchor III Shares - - E Shares 56,376 585,597 Standard A Shares 1,021,426 10,525,852 (1) Inclusive of Shares issued pursuant to the Company’s distribution reinvestm”

Warburg Pincus Access Fund, L.P. issued 2,433,500 Units of unit to third-party investors for $60,837,500.

“sold unregistered limited partnership units (the “Units”) for aggregate consideration of $61,585,160. The following table provides details on the Units sold to third-party investors by the Fund: Unit Class Number of Units Sold (1) Aggregate Consideration (1) Class B-1 2,433,500 $ 60,837,500”

Suncrete, Inc. issued common stock to additional PIPE Investor for commitment amount of $61.6 million.

“On March 27, 2026, Haymaker and PubCo entered into a subscription agreement (the “New Subscription Agreement”) with an additional PIPE Investor for a commitment amount of $61.6 million”

Suncrete, Inc. issued 26,000 shares of Series A Convertible Perpetual Preferred Stock of preferred stock to holders of Suncrete's Senior Preferred Units for Senior Preferred Units.

“PubCo agreed to issue an aggregate of 26,000 shares of Series A Convertible Perpetual Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), to such Senior Preferred Unit holders in exchange for their Senior Preferred Units”

KPET Ultra Paceline Corp issued 235,000 units of unit to KPET Ultra Paceline Unit Holdings, LLC for $10.00 per Private Placement Unit.

“On April 1, 2026, simultaneously with the closing of the IPO and pursuant to the Purchase Agreement, the Company completed the private sale of 235,000 units (the “ Private Placement Units ”) at a purchase price of $10.00 per Private Placement Unit to Unit Holder Sponsor, generating gross proceeds to the Company of $2,350,000.”

GULF RESOURCES, INC. issued 60,000 shares of common stock of common stock to a Private Placement Purchaser for aggregate purchase price of US$246,000.

“Pursuant to the agreement dated March 28, 2026, the Company agreed to sell and issue 60,000 shares of common stock to a Private Placement Purchaser for an aggregate purchase price of US$246,000.”

GULF RESOURCES, INC. issued 70,000 shares of common stock of common stock to a Private Placement Purchaser for aggregate purchase price of US$275,800.

“Pursuant to the agreement dated March 19, 2026, the Company agreed to sell and issue 70,000 shares of common stock to a Private Placement Purchaser for an aggregate purchase price of US$275,800.”

GULF RESOURCES, INC. issued 75,000 shares of common stock of common stock to a Private Placement Purchaser for aggregate purchase price of US$267,750.

“Pursuant to the agreement dated March 5, 2026, the Company agreed to sell and issue 75,000 shares of common stock to a Private Placement Purchaser for an aggregate purchase price of US$267,750.”

GULF RESOURCES, INC. issued 69,000 shares of common stock of common stock to four individual investors for aggregate purchase price of US$246,330.

“to the agreement dated January 26, the Company agreed to sell and issue 69,000 shares of common stock to a Private Placement Purchaser for an aggregate purchase price of US$246,330. Pursuant to the agreement dated March 5, 2026, the Company agreed to sell and issue 75,000 shares of common stock to a Private Placement Purchaser for an aggregate purchase”

ONCOLYTICS BIOTECH INC issued common stock.

“On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the "Articles of Domestication"); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the "Articles of Incorporation").”

QXO, Inc. issued preferred stock.

“On April 1, 2026, QXO filed a certificate of designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to establish the preferences, limitations and relative rights of QXO’s Series C Convertible Perpetual Preferred Stock (the “Series C Preferred Stock”).”

Keurig Dr Pepper Inc. issued 4,500,000 shares of preferred stock to KKR Investor, Apollo Investor and certain other investors (Preferred Investors) for $4.5 billion aggregate purchase price, $1,000 per share.

“On March 30, 2026, Keurig Dr Pepper Inc. (“KDP” or the “Company”) issued and sold, for an aggregate purchase price of $4.5 billion, 4,500,000 shares of its newly created Series A Convertible Perpetual Preferred Stock, par value $0.01 per share (the “Convertible Preferred Stock”), at a price of $1,000 per share, pursuant to an Investment Agreement, dated as of October 27, 2025, by and among the Company, Pour Purchaser L.P. (together with its affiliates, the “KKR Investor”), AP Pour Holdings, L.P. (together with its affiliates, the “Apollo Investor”) and certain other investors party thereto (collectively with any other investor that becomes party thereto, the “Preferred Investors”)”

Cottonwood Communities, Inc. issued 130,077 shares of Series 2025 Preferred Stock of preferred stock to accredited investors for aggregate proceeds of $1,277,000.

“During the period from March 16, 2026 through March 31, 2026, we issued and sold 130,077 shares of Series 2025 Preferred Stock in the Series 2025 Private Offering and received aggregate proceeds of $1,277,000.”

Cottonwood Communities, Inc. issued 239,119 shares of Series A Convertible Preferred Stock of preferred stock to accredited investors for aggregate proceeds of $2,369,181.

“During the period from March 11, 2026 through March 31, 2026, we issued and sold 239,119 shares of Series A Convertible Preferred Stock in the Series A Convertible Private Offering and received aggregate proceeds of $2,369,181.”

Lafayette Square USA, Inc. issued approximately 1.4 million shares of common stock to accredited investors for aggregate offering price of approximately $20.9 million.

“On March 27, 2026, pursuant to a drawdown notice previously delivered to investors, Lafayette Square USA, Inc. (the “Company”) sold approximately 1.4 million shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), for an aggregate offering price of approximately $20.9 million.”

Cadrenal Therapeutics, Inc. issued 37,143 shares of Common Stock of warrant to H.C. Wainwright & Co., LLC for exercise price of $5.625 per share.

“Shares. The Placement Agent Warrants will have substantially the same terms as the Series B-1 Warrants, except that the Placement Agent Warrants will have an exercise price of $5.625 per share, which is equal to 125% of the exercise price of the New Warrants. 1 Terms of the New Warrants The New Warrants will be immediately exercisable at an exercise price of”

Cadrenal Therapeutics, Inc. issued 571,430 shares of Common Stock of warrant to Holder of Existing Warrants for exercise price of $4.50 per share.

“of the Existing Warrants agreed to exercise for cash the Existing Warrants to purchase up to an aggregate of 571,430 shares of Common Stock, at the adjusted exercise price of $4.50 per share (reduced from the initial exercise price of $16.50 per share). The offer and resale of the shares of Common Stock underlying the Existing Warrants (the “Existing Warrant”

Grayscale Bittensor Trust (TAO) issued 121,300 Shares of common stock to selected "accredited investors" for an aggregate of 2,322.50581174 TAO representing $715,103.

“Since the sales reported on the most recently filed Annual Report on Form 10-K by Grayscale Bittensor Trust (TAO) (the “Trust”), the Trust issued 121,300 Shares at varying prices determined by reference to its NAV per Share to selected “accredited investors,” within the meaning of Rule 501 of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”), in private placement transactions exempt from the registration requirements of the Securities Act pursuant to Rule 506(c) thereunder for an aggregate of 2,322.50581174 TAO representing $715,103.”

Versigent PLC issued 70,892,660 ordinary shares of common stock to Aptiv PLC for transfer of certain entities that are part of Aptiv’s Electrical Distribution Systems segment.

“On March 26, 2026, in connection with the Spin-Off, the Company issued 70,892,660 ordinary shares to Aptiv in consideration for the transfer of certain entities that are part of Aptiv’s Electrical Distribution Systems segment.”

QDRO Acquisition Corp. issued aggregate of 6,000,000 warrants of warrant to the Sponsor and the Underwriter for $1.00 per Private Placement Warrant.

“Simultaneously with the closing of the IPO, pursuant to the Warrant Purchase Agreements, the Company completed the private sale of an aggregate of 6,000,000 warrants (the “ Private Placement Warrants ”) to the Sponsor and the Underwriter at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $6,000,000.”

Future Money Acquisition Corp issued 304,000 units of unit to the Sponsor for $10.00 per Private Placement Unit.

“the Company completed the private sale of an aggregate of 304,000 units (the “Private Placement Units”) to the Sponsor at a price of $10.00 per Private Placement Unit, generating total gross proceeds of $3,040,000.”

SCYNEXIS INC issued 34,750,000 shares of common stock, 8,750,000 pre-funded warrants to purchase common stock, and 43,500,000 common warrants to purchase common stock (each common of unit to institutional and accredited investors including Great Point Partners, LLC, Squadron Capital Management LLC, Adage Capital Management, L.P., Propel Bio Partners, a large healthcare-dedicated fund, and David Angulo, the Company's President and CEO for Combined purchase price of $0.92 per common share and accompanying common warrant, and $0.9199 per pre-funded warrant and accompanying common warrant; total upf.

“Pursuant to the terms of the securities purchase agreement, the Company will issue an aggregate of (i) 34,750,000 shares of its common stock, $0.001 par value per share (the “Common Shares”), (ii) pre-funded warrants to purchase up to 8,750,000 shares of common stock (the “Pre-Funded Warrants”) and (iii) accompanying common warrants to purchase up to an aggregate 43,500,000 shares of common stock or pre-funded warrants in lieu thereof (the “Common Warrants”). The aggregate share issuance includes 108,695 Common Shares and accompanying Common Warrants that were sold to the Company’s President and Chief Executive Officer, Dr. David Angulo. Each Common Share (or Pre-Funded Warrant) will be accompanied by one Common Warrant. The Common Shares and accompanying Common Warrants were sold at a combined price of $0.92 per Common Share and accompanying Common Warrant, and 8,750,000 Pre-Funded Warrants and accompanying Common Warrants were sold at a combined price of $0.9199 per Pre-Funded Warran”

BATTALION OIL CORP issued 1,800,000 shares of common stock to Luminus Energy Partners Master Fund, Ltd. for conversion of 7,803 shares of Series A-2 Preferred Stock, conversion price $6.21 per share.

“On March 30, 2026, Battalion Oil Corporation (the “ Company ”) issued 1,800,000 shares of its common stock, par value $0.0001 per share (the “Common Stock ”), to Luminus Energy Partners Master Fund, Ltd. (“ Luminus ”) upon the conversion of 7,803 shares of the Company’s Series A-2 Redeemable Convertible Preferred Stock, par value $0.0001 per share (the “ Series A-2 Preferred Stock ”).”

XMax Inc. issued 1,958,000 shares of common stock to StratoCore Solutions Ltd. for $3.575 per share for an aggregate offering price of $6,999,850.

“On March 30, 2026, XMax Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Agreement ”) with StratoCore Solutions Ltd., a Malaysian company (the “ Purchaser ”), pursuant to which the Company agreed to sell to the Purchaser in a private placement 1,958,000 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), at a purchase price of $3.575 per share for an aggregate offering price of $6,999,850 (the “ Private Placement ”).”

Sow Good Inc. issued 1,500,000 shares of Series AAA Convertible Redeemable Preferred Stock of preferred stock to David Lazar (assigned to PanamaCo and other investors) for $3,000,000.

“Transfer”). PanamaCo subsequently transferred some of the rights to a number of investors who together with PanamaCo paid the purchase price of the Series AAA Preferred Stock of $3,000,000. The Company intends on using the proceeds from the offering for general corporate purposes and working capital. On March 31, 2026 (the “Filing Date”), the Company filed a”

ZeroStack Corp. issued warrant.

“ZeroStack will issue an aggregate of 9,104,614 common shares, no par value of the Company (the “ ZeroStack Shares ”) and/or pre-funded warrants of the Company (the “ ZeroStack Pre-funded Warrants ” and together with the ZeroStack Shares, the “ ZeroStack Securities ”) in exchange for an aggregate of 9,104,614 Blocker Shares”

ZeroStack Corp. issued an aggregate of 9,104,614 common shares of common stock.

“ZeroStack will issue an aggregate of 9,104,614 common shares, no par value of the Company (the “ ZeroStack Shares ”) and/or pre-funded warrants of the Company (the “ ZeroStack Pre-funded Warrants ” and together with the ZeroStack Shares, the “ ZeroStack Securities ”) in exchange for an aggregate of 9,104,614 Blocker Shares”